A Phase 1, Open-label, Multi-center Study to Determine the PK and Safety of Solithromycin as Add-on Therapy in Adolescents With Suspected or Confirmed Bacterial Infection

Trial Profile

A Phase 1, Open-label, Multi-center Study to Determine the PK and Safety of Solithromycin as Add-on Therapy in Adolescents With Suspected or Confirmed Bacterial Infection

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Solithromycin (Primary) ; Solithromycin (Primary)
  • Indications Bacterial infections
  • Focus Pharmacokinetics
  • Sponsors Cempra Pharmaceuticals
  • Most Recent Events

    • 17 Apr 2015 According to a Cempra Pharmaceuticals media release, results from this trial will be presented at the 2015 Pediatric Academic Societies (PAS) Annual Meeting.
    • 22 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Dec 2013 Planned initiation date changed from 1 Nov 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top